About
Doug Cole, M.D. is a Managing Partner at Flagship Pioneering, where he has worked since 2001 focusing on life sciences venture creation and investing. He is a physician by training, formerly held roles at Harvard Medical School, Massachusetts General Hospital, Cytotherapeutics, and Vertex, and has co-founded or helped build multiple biotech companies including Moderna, Foghorn Therapeutics, Vesalius Therapeutics, and Syros Pharmaceuticals. He also serves or has served on numerous biotech boards, including Denali Therapeutics, Foghorn Therapeutics, KSQ Therapeutics, Harbinger Health, Repertoire Immune Medicines, Sana Biotechnology, and Sigilon Therapeutics.
Areas of interest
biotechlife sciencestherapeuticsdrug discoverygenomicsgene regulationmRNAneurologyneurodegenerative diseaseoncologyautoimmune diseaserare diseaseAI in drug discoveryprecision medicine